Wall Street dives into Regeneron’s robust prospects By Investing.com
Regeneron (NASDAQ:) Pharmaceuticals, Inc. remains... At the forefront of the biopharmaceutical industry, with a strategic focus on new therapeutic areas and a strong financial position. Analysts from BMO Capital Markets, Morgan Stanley…